BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gour A, Manhas D, Bag S, Gorain B, Nandi U. Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS-CoV-2. Phytother Res 2021;35:4258-83. [PMID: 33786876 DOI: 10.1002/ptr.7092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ribeiro TDS, Stechi G, Castro PCD, Viana AL. Comunicação em saúde sobre COVID-19 e Diabetes Mellitus em mídias sociais: verdadeiro e falso. Esc Anna Nery 2022;26:e20210358. [DOI: 10.1590/2177-9465-ean-2021-0358] [Reference Citation Analysis]
2 Pagano E. Phytocompounds and COVID-19: Two years of knowledge. Phytother Res 2022. [PMID: 35170093 DOI: 10.1002/ptr.7420] [Reference Citation Analysis]
3 Yao J, Zhang Y, Wang XZ, Zhao J, Yang ZJ, Lin YP, Sun L, Lu QY, Fan GJ. Flavonoids for Treating Viral Acute Respiratory Tract Infections: A Systematic Review and Meta-Analysis of 30 Randomized Controlled Trials. Front Public Health 2022;10:814669. [PMID: 35252093 DOI: 10.3389/fpubh.2022.814669] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Md S, Alhakamy NA, Sharma P, Ansari MS, Gorain B. Nanocarrier-based co-delivery approaches of chemotherapeutics with natural P-glycoprotein inhibitors in the improvement of multidrug resistance cancer therapy. Journal of Drug Targeting. [DOI: 10.1080/1061186x.2022.2069782] [Reference Citation Analysis]
5 Al-Kuraishy HM, Al-Gareeb AI, Kaushik A, Kujawska M, Batiha GE. Ginkgo biloba in the management of the COVID-19 severity. Arch Pharm (Weinheim) 2022;:e2200188. [PMID: 35672257 DOI: 10.1002/ardp.202200188] [Reference Citation Analysis]
6 Khazeei Tabari MA, Iranpanah A, Bahramsoltani R, Rahimi R. Flavonoids as Promising Antiviral Agents against SARS-CoV-2 Infection: A Mechanistic Review. Molecules 2021;26:3900. [PMID: 34202374 DOI: 10.3390/molecules26133900] [Reference Citation Analysis]
7 Hamdy R, Mostafa A, Abo Shama NM, Soliman SSM, Fayed B. Comparative evaluation of flavonoids reveals the superiority and promising inhibition activity of silibinin against SARS-CoV-2. Phytother Res 2022. [PMID: 35596627 DOI: 10.1002/ptr.7486] [Reference Citation Analysis]
8 Theoharides TC. Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome? Mol Neurobiol 2022. [PMID: 35028901 DOI: 10.1007/s12035-021-02696-0] [Reference Citation Analysis]
9 Jannat K, Paul AK, Bondhon TA, Hasan A, Nawaz M, Jahan R, Mahboob T, Nissapatorn V, Wilairatana P, Pereira ML, Rahmatullah M. Nanotechnology Applications of Flavonoids for Viral Diseases. Pharmaceutics 2021;13:1895. [PMID: 34834309 DOI: 10.3390/pharmaceutics13111895] [Reference Citation Analysis]
10 Al-rajhi AMH, Yahya R, Abdelghany TM, Fareid MA, Mohamed AM, Amin BH, Masrahi AS. Anticancer, Anticoagulant, Antioxidant and Antimicrobial Activities of Thevetia peruviana Latex with Molecular Docking of Antimicrobial and Anticancer Activities. Molecules 2022;27:3165. [DOI: 10.3390/molecules27103165] [Reference Citation Analysis]
11 Bardelčíková A, Miroššay A, Šoltýs J, Mojžiš J. Therapeutic and prophylactic effect of flavonoids in post-COVID-19 therapy. Phytother Res 2022. [PMID: 35302260 DOI: 10.1002/ptr.7436] [Reference Citation Analysis]
12 Liu X, Lou L, Zhou L. Molecular Mechanisms of Cardiac Injury Associated With Myocardial SARS-CoV-2 Infection. Front Cardiovasc Med 2022;8:643958. [DOI: 10.3389/fcvm.2021.643958] [Reference Citation Analysis]